324 related articles for article (PubMed ID: 27598235)
1. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agent.
Yousuf M; Mukherjee D; Dey S; Chatterjee S; Pal A; Sarkar B; Pal C; Adhikari S
Bioorg Med Chem Lett; 2018 Apr; 28(6):1056-1062. PubMed ID: 29478704
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
5. Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
Castera-Ducros C; Paloque L; Verhaeghe P; Casanova M; Cantelli C; Hutter S; Tanguy F; Laget M; Remusat V; Cohen A; Crozet MD; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2013 Nov; 21(22):7155-64. PubMed ID: 24080103
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis.
Upadhyay A; Chandrakar P; Gupta S; Parmar N; Singh SK; Rashid M; Kushwaha P; Wahajuddin M; Sashidhara KV; Kar S
J Med Chem; 2019 Jun; 62(11):5655-5671. PubMed ID: 31124675
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
[TBL] [Abstract][Full Text] [Related]
8. Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes.
Hazra S; Ghosh S; Debnath S; Seville S; Prajapati VK; Wright CW; Sundar S; Hazra B
Parasitol Res; 2012 Jul; 111(1):195-203. PubMed ID: 22297912
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of perspicamide A and related diverse analogues: their bioevaluation as potent antileishmanial agents.
Pandey AK; Sharma R; Shivahare R; Arora A; Rastogi N; Gupta S; Chauhan PM
J Org Chem; 2013 Feb; 78(4):1534-46. PubMed ID: 23289499
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
12. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
16. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
17. Arylthiosemicarbazones as antileishmanial agents.
Manzano JI; Cochet F; Boucherle B; Gómez-Pérez V; Boumendjel A; Gamarro F; Peuchmaur M
Eur J Med Chem; 2016 Nov; 123():161-170. PubMed ID: 27475107
[TBL] [Abstract][Full Text] [Related]
18. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
